|
CWA's Experience
Capital West Advisors is one of the most experienced life science planning firms in the U.S. and is extremely experienced with life science companies. CWA has 4 staff members with life science business planning experience. Seth Schwartz previously worked at the Kriegsman Group, which specialized in procuring investment capital for life science companies. CWA develops world-class life science business plans and is very experienced with pharmaceuticals, biotechnology, medical devices, and medical supplies. Numerous CWA life science clients that CWA developed business plans for have secured capital.
Unique Elements of a Biotech & Pharmaceutical Business Plan
A biotechnology business plan or pharmaceutical business plan should closely detail the development plan of the product(s) and the several stages of FDA clinical trials that each product has already passed and/or still needs to conduct and pass. The product (or technology) section should provide a strong technical description of the product, compound, or technology being developed and should often contain a "Competing Technologies" section, which technically describes similar and competing technologies.
The market section should closely focus on the specific market for that category of drug, device, or compound and include statistics regarding the various diseases that the business will treat. The financial plan should closely detail the projected costs of research, development, equipment, and salaries that the business will incur to bring the product to market and beyond. A biotech or pharmaceutical business plan is typically approximately 25 to 35 pages in length and can contain an Appendix with data from clinical trials and/or intellectual property pertaining to the product. Biotechnology and pharmaceutical business plans typically range from $3000 to $5500 to develop a full business plan.
|
|
|
